276 related articles for article (PubMed ID: 17176756)
1. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
Walencka E; Sadowska B; Rózalska S; Hryniewicz W; Rózalska B
Folia Microbiol (Praha); 2006; 51(5):381-6. PubMed ID: 17176756
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Steinkraus G; White R; Friedrich L
J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial/anti-biofilm activity of expired blood platelets and their released products.
Różalski MI; Micota B; Sadowska B; Paszkiewicz M; Więckowska-Szakiel M; Różalska B
Postepy Hig Med Dosw (Online); 2013 Apr; 67():321-5. PubMed ID: 23619231
[TBL] [Abstract][Full Text] [Related]
4. Effect of sub-lethal doses of vancomycin and oxacillin on biofilm formation by vancomycin intermediate resistant Staphylococcus aureus.
Mirani ZA; Jamil N
J Basic Microbiol; 2011 Apr; 51(2):191-5. PubMed ID: 20967790
[TBL] [Abstract][Full Text] [Related]
5. Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication.
Walencka E; Sadowska B; Rozalska S; Hryniewicz W; Rózalska B
Pol J Microbiol; 2005; 54(3):191-200. PubMed ID: 16450834
[TBL] [Abstract][Full Text] [Related]
6. Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.
Wu JA; Kusuma C; Mond JJ; Kokai-Kun JF
Antimicrob Agents Chemother; 2003 Nov; 47(11):3407-14. PubMed ID: 14576095
[TBL] [Abstract][Full Text] [Related]
7. In vitro efficacy of antimicrobial agents against high-inoculum or biofilm-embedded meticillin-resistant Staphylococcus aureus with vancomycin minimal inhibitory concentrations equal to 2 μg/mL (VA2-MRSA).
Tang HJ; Chen CC; Ko WC; Yu WL; Chiang SR; Chuang YC
Int J Antimicrob Agents; 2011 Jul; 38(1):46-51. PubMed ID: 21549575
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
Metallidis S; Chatzidimitriou M; Nikolaidis P; Tsona A; Bisiklis A; Kollaras P; Tsiakiri E; Koumentaki E; Alexiou-Daniel S
J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.
El-Azizi M; Rao S; Kanchanapoom T; Khardori N
Ann Clin Microbiol Antimicrob; 2005 Jan; 4():2. PubMed ID: 15638934
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus.
Yang W; Liu J; Blažeković B; Sun Y; Ma S; Ren C; Vladimir-Knežević S; Li C; Xing Y; Tian G; Wang Y
BMC Complement Altern Med; 2018 May; 18(1):169. PubMed ID: 29848316
[TBL] [Abstract][Full Text] [Related]
11. Minimal inhibitory concentration drift of glycopeptides and linezolid against S. Aureus at a Chinese children's center, 2009-2013.
Jing CM; Xie W; Chen Y; Wang C
Pediatr Infect Dis J; 2015 Jan; 34(1):108-11. PubMed ID: 25741804
[TBL] [Abstract][Full Text] [Related]
12. Comparison of linezolid and vancomycin lock solutions with and without heparin against biofilm-producing bacteria.
Luther MK; Mermel LA; LaPlante KL
Am J Health Syst Pharm; 2017 May; 74(9):e193-e201. PubMed ID: 28438824
[TBL] [Abstract][Full Text] [Related]
13. Biofilm formation and dispersal of Staphylococcus aureus under the influence of oxacillin.
Mirani ZA; Aziz M; Khan MN; Lal I; Hassan NU; Khan SI
Microb Pathog; 2013; 61-62():66-72. PubMed ID: 23711963
[TBL] [Abstract][Full Text] [Related]
14. Multiple Low Frequency Ultrasound Enhances Bactericidal Activity of Vancomycin against Methicillin-Resistant
Wang J; Wen K; Liu X; Weng CX; Wang R; Cai Y
Biomed Res Int; 2018; 2018():6023101. PubMed ID: 30364019
[TBL] [Abstract][Full Text] [Related]
15. Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates.
Abdelraheem WM; Khairy RMM; Zaki AI; Zaki SH
Ann Clin Microbiol Antimicrob; 2021 Aug; 20(1):54. PubMed ID: 34419054
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Silvestri C; Licci A; De Fusco M; Provinciali M; Saba V; Scalise G
Antimicrob Agents Chemother; 2005 Oct; 49(10):4042-5. PubMed ID: 16189078
[TBL] [Abstract][Full Text] [Related]
17. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
[TBL] [Abstract][Full Text] [Related]
18. Comparison of in vitro efficacy of linezolid and vancomycin by determining their minimum inhibitory concentrations against methicillin resistant Staphylococcus aureus (MRSA).
Kaleem F; Usman J; Khalid A; Hassan A; Omair M
J Pak Med Assoc; 2011 Apr; 61(4):356-9. PubMed ID: 21465972
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey.
Tekin A; Dal T; Deveci Ö; Tekin R; Özcan N; Atmaca S; Dayan S
Braz J Microbiol; 2014; 45(3):829-33. PubMed ID: 25477914
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
